Ownership Submission

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

FEINBERG LARRY N

2. Issuer Name and Ticker or Trading Symbol
ACCESS PHARMACEUTICALS INC [ACCP]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	__X__ 10% Owner
_____ Officer (give title below)	_____ Other (specify below)

(Last)

(First)

(Middle)

C/O ORACLE ASSOCIATES, LLC, 200 GREENWICH AVENUE, 3RD FLOOR

3. Date of Earliest Transaction (Month/Day/Year)
02/01/2005

(Street)

GREENWICH, CT 06830

4. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $0.01 per share ("Common Stock")	02/01/2005		P		30,200	A	$ 2.69	1,242,500 ⁽²⁾ ⁽³⁾	I	See footnote ⁽¹⁾
Common Stock	02/01/2005		S		30,200	D	$ 2.69	1,242,500 ⁽²⁾ ⁽³⁾	I	See footnote ⁽¹⁾
Common Stock	12/31/2005		P		15,636	A	$ 0.65	1,718,121 ⁽²⁾ ⁽³⁾	I	See footnote ⁽¹⁾
Common Stock	12/31/2005		P		82,745	A	$ 0.65	1,718,121 ⁽²⁾ ⁽³⁾	I	See footnote ⁽¹⁾
Common Stock	12/31/2005		P		299,056	A	$ 0.65	1,718,121 ⁽²⁾ ⁽³⁾	I	See footnote ⁽¹⁾
Common Stock	12/31/2005		P		78,184	A	$ 0.65	1,718,121 ⁽²⁾ ⁽³⁾	I	See footnote ⁽¹⁾
Common Stock	06/05/2006		J		1,374,497	D	⁽⁴⁾	343,624 ⁽²⁾ ⁽³⁾	I	See footnote ⁽¹⁾
Common Stock	09/01/2006		S		0.80	D	⁽⁵⁾	343,623 ⁽²⁾ ⁽³⁾	I	See footnote ⁽¹⁾
Common Stock	09/01/2006		S		0.20	D	⁽⁵⁾	343,623 ⁽²⁾ ⁽³⁾	I	See footnote ⁽¹⁾
Common Stock	09/01/2006		S		0.20	D	⁽⁵⁾	343,623 ⁽²⁾ ⁽³⁾	I	See footnote ⁽¹⁾
Common Stock	01/22/2007		S		6,040	D	$ 2.53	343,623 ⁽²⁾ ⁽³⁾	I	See footnote ⁽¹⁾
Common Stock	01/22/2007		P		6,040	A	$ 2.53	343,623 ⁽²⁾ ⁽³⁾	I	See footnote ⁽¹⁾
Common Stock	02/26/2007		S		19,000	D	$ 7.314	318,623 ⁽²⁾ ⁽³⁾	I	See footnote ⁽¹⁾
Common Stock	02/26/2007		S		5,000	D	$ 7.314	318,623 ⁽²⁾ ⁽³⁾	I	See footnote ⁽¹⁾
Common Stock	02/26/2007		S		1,000	D	$ 7.314	318,623 ⁽²⁾ ⁽³⁾	I	See footnote ⁽¹⁾
Common Stock	02/27/2007		S		300	D	$ 7	318,223 ⁽²⁾ ⁽³⁾	I	See footnote ⁽¹⁾
Common Stock	02/27/2007		S		100	D	$ 7	318,223 ⁽²⁾ ⁽³⁾	I	See footnote ⁽¹⁾
Common Stock	02/28/2007		S		10,000	D	$ 7.10	302,523 ⁽²⁾ ⁽³⁾	I	See footnote ⁽¹⁾
Common Stock	02/28/2007		S		4,500	D	$ 7.10	302,523 ⁽²⁾ ⁽³⁾	I	See footnote ⁽¹⁾
Common Stock	03/01/2007		S		1,200	D	$ 7.125	302,523 ⁽²⁾ ⁽³⁾	I	See footnote ⁽¹⁾
Common Stock	06/19/2007		S		40,000	D	$ 5.17	302,523 ⁽²⁾ ⁽³⁾	I	See footnote ⁽¹⁾
Common Stock	06/19/2007		S		20,000	D	$ 5.17	302,523 ⁽²⁾ ⁽³⁾	I	See footnote ⁽¹⁾
Common Stock	06/19/2007		P		60,000	A	$ 5.17	302,523 ⁽²⁾ ⁽³⁾	I	See footnote ⁽¹⁾
Common Stock	07/23/2007		S		4,000	D	$ 4.3563	298,523 ⁽²⁾ ⁽³⁾	I	See footnote ⁽¹⁾
Common Stock	07/24/2007		S		2,040	D	$ 4.35	296,483 ⁽²⁾ ⁽³⁾	I	See footnote ⁽¹⁾
Common Stock	02/12/2008		P		29,736	A	$ 3.15	296,483 ⁽²⁾ ⁽³⁾	I	See footnote ⁽¹⁾
Common Stock	02/12/2008		S		29,736	D	$ 3.15	296,483 ⁽²⁾ ⁽³⁾	I	See footnote ⁽¹⁾

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Series A Cumulative Convertible Preferred Stock

⁽⁶⁾

11/10/2007

J⁽⁷⁾

437

⁽⁶⁾

Common Stock

1,457,707

⁽⁷⁾

437

See footnote ⁽¹⁾

Common Stock Purchase Warrants

⁽⁹⁾

11/10/2007

J⁽⁷⁾

728,850

⁽⁹⁾

Common Stock

728,850

⁽⁷⁾

728,850

See footnote ⁽¹⁾

Series A Cumulative Convertible Preferred Stock

⁽⁶⁾

03/11/2008

⁽⁶⁾

Common Stock

240,000

⁽⁸⁾

See footnote ⁽¹⁾

Series A Cumulative Convertible Preferred Stock

⁽⁶⁾

03/11/2008

⁽⁶⁾

Common Stock

240,000

⁽⁸⁾

See footnote ⁽¹⁾

Common Stock Purchase Warrants

⁽⁹⁾

03/11/2008

119,811

⁽⁹⁾

Common Stock

119,811

⁽⁸⁾

119,811

See footnote ⁽¹⁾

Common Stock Purchase Warrants

⁽⁹⁾

03/11/2008

119,811

⁽⁹⁾

Common Stock

119,811

⁽⁸⁾

119,811

See footnote ⁽¹⁾

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
FEINBERG LARRY N C/O ORACLE ASSOCIATES, LLC 200 GREENWICH AVENUE, 3RD FLOOR GREENWICH, CT 06830		X
Oracle Associates LLC 200 GREENWICH AVENUE, 3RD FLOOR GREENWICH, CT 06830		X
ORACLE PARTNERS LP C/O ORACLE ASSOCIATES, LLC 200 GREENWICH AVENUE, 3RD FLOOR GREENWICH, CT 06830		X
ORACLE INSTITUTIONAL PARTNERS L P C/O ORACLE ASSOCIATES, LLC 200 GREENWICH AVENUE, 3RD FLOOR GREENWICH, CT 06830		X
ORACLE INVESTMENT MANAGEMENT INC 200 GREENWICH AVE, 3RD FLOOR GREENWICH, CT 06830		X

Signatures

/s/ Larry N. Feinberg		06/10/2008
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	See Exhibit 99.1.
(2)	See Exhibit 99.1.
(3)	See Exhibit 99.1.
(4)	See Exhibit 99.1.
(5)	See Exhibit 99.1.
(6)	See Exhibit 99.1.
(7)	See Exhibit 99.1.
(8)	See Exhibit 99.1.
(9)	See Exhibit 99.1.
Remarks: (10) - (15) See Exhibit 99.1. Exhibit List: Exhibit 99.1 - Explanation of Responses Exhibit 99.2 - Joint Filer Information for Oracle Associates Exhibit 99.3 - Joint Filer Information for Oracle Partners Exhibit 99.4 - Joint Filer Information for Oracle Institutional Partners Exhibit 99.5 - Joint Filer Information for Oracle Investment Management

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.